secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibikase Therapeutics, Inc. (IKT)
CIK:        0001750149
Form:       8-K
Filed at:   2023-07-17T23:59:59+00:00
Accession:  0001193125-23-188223
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inhibikase regains Nasdaq minimum bid price compliance
------------------------------------------------------

- Received Nasdaq notice on July 17, 2023 confirming compliance with Listing Rule 5550(a)(2).
- Closing bid price was at or above $1.00 for 10 consecutive business days ended July 14, 2023.
- The matter is closed; no further action required from the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750149/000119312523188223/0001193125-23-188223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750149/000119312523188223/d510291d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-188223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer